AssetMark Inc’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

AssetMark Inc’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,555	Closed	-$21K	–	1573
2018 Q4	$21K	Sell	1,555 -116	-7%	-$1.96K	﹤0.01%	891
2018 Q3	$32K	Buy	1,671 +205	+14%	+$4.37K	﹤0.01%	837
2018 Q2	$37K	Hold	1,466	–	–	﹤0.01%	790
2018 Q1	$30K	Sell	1,466 -16	-1%	-$373	﹤0.01%	865
2017 Q4	$30K	Buy	1,482 +16	+1%	+$315	﹤0.01%	927
2017 Q3	$30K	Buy	1,466 +590	+67%	+$9.98K	﹤0.01%	833
2017 Q2	$13K	Hold	876	–	–	﹤0.01%	994
2017 Q1	$14K	Hold	876	–	–	﹤0.01%	944
2016 Q4	$11K	Hold	876	–	–	﹤0.01%	965
2016 Q3	$25K	Sell	876 -9	-1%	-$302	﹤0.01%	818
2016 Q2	$31K	Hold	885	–	–	﹤0.01%	736
2016 Q1	$24K	Sell	885 -12	-1%	-$353	﹤0.01%	730
2015 Q4	$31K	Buy	+897	New	+$28K	﹤0.01%	722

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AssetMark Inc's DPLO Position: Q1 2019 in Review

AssetMark Inc sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2019, closing a stake of 1,555 shares — an estimated $21K sold.

AssetMark Inc first reported a position in DPLO in Q4 2015 and held it in 13 quarters. The position peaked at $37K in Q2 2018. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

AssetMark Inc reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2019 after selling out during the quarter.
AssetMark Inc sold 1,555 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $21K.
AssetMark Inc first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 13 quarters.
AssetMark Inc's DIPLOMAT PHARMACY, INC. position peaked at $37K in Q2 2018.
150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on AssetMark Inc's 13F filing for Q1 2019, filed 14 May 2019.